Status:
COMPLETED
A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
Lead Sponsor:
Indiana University School of Medicine
Conditions:
End-Stage Renal Disease Patients on Hemodialysis
Eligibility:
All Genders
18-82 years
Phase:
NA
Brief Summary
The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Age \<18
- Pregnant individuals
- Fish oil or omega-3 supplementation in past 6 months
- Fish, corn, soybean, gelatin, or vanilla allergies
- Currently enrolled in a dietary or investigational drug study
- Life expectancy \< 3 months
- Ongoing active illness requiring hospitalization
- Malabsorption syndromes
- Chronic heparin or coumadin anticoagulation (??)
- Active bleeding issues
Exclusion
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00308295
Start Date
April 1 2006
End Date
May 1 2006
Last Update
October 16 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Nephrology Clinics
Indianapolis, Indiana, United States, 46202
2
VeteransAdministration Hospital
Indianapolis, Indiana, United States, 46202